Tolerability of switch from erenumab to fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, real-world, observational study

Abstract Objective While erenumab and fremanezumab are effective treatments for migraine prevention, it is unclear whether patients who experience adverse events related to erenumab can tolerate fremanezumab. This study evaluated the tolerability of switching from erenumab to fremanezumab in patient...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Faisal Mohammad Amin, Thor Linnet, Christopher Kjaer Cullum, Thien Phu Do, Samaira Younis
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-07-01
Colecção:	The Journal of Headache and Pain
Assuntos:	Calcitonin gene-related peptide CGRP Headache Constipation Gastrointestinal symptoms Migraine with aura
Acesso em linha:	https://doi.org/10.1186/s10194-025-02087-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!